Great Basin's Staph ID/R Blood Culture Panel is a sample-to-result, automated, DNA multiplex assay for simultaneous identification of Staphylococcus aureus and Staphylococcus species directly from positive blood cultures in about 2 hours. The panel also detects the mecA gene, a major drug resistance marker that confers resistance to methicillin and other beta-lactams and creates the superbug MRSA.
Sentiment: Strong Buy
Though I don't like reverse split, the news today will start pumping money into GBSN and the reverse split will become a distant memory.
Sentiment: Strong Buy
Initially I was dissappointed by earnings being pushed out to end of this month. Also I was disspointed by lack of price movement, But I am jumping back in pre-announcement.
Pushing the the earnings release until the end of the month can be for a number of reasons;
1) Getting ready for a potential buyout
2) Moving off Pinksheets to another exchange ( Ilya Nikolayev has mentioned this desire in the past to improve investor equity)
3) Forecast earnings for the next qtr and next year, like a real company
Any of these reasons requires the books to be as acccurate as possible. They have never really provided forecast numbers in the past and they likely weren't on the position to have good future visibility. Now they do so this could be the #1 reason for getting the numbers straight. Ilya has a strong reason to get TAPM above $1.
My best guess is that Ilya wants to move from Pinks Sheets to OTCBB, which requires filing a quarterly financial report with the SEC, while companies on Pink Sheets are not required to report financial statements. This would easily explain taking longer in March to ensure they report quarterly thereafter.
I am not a fan of reverse splits, but it was punished after the announcement down to 16 cents.
And it seems overlooked now, that they will have 2 products on the market shortly. The Multiplex Panel and Shiga Toxin test will be in demand.
The opening price equated to14 cents pre split. If it were to trade near the 30 cent pre split high , that would equate to $9-10.
$6 is a good entry point today
If BlueBalls can continually reply to his own messages, so can I. LOL
I repeat, they have products that will be in demand!!
GBSN was already punished when the reverse split was initially announced.
You guys are funny... do you realize that for the last 2 hours your pumping and bashing has had little effect. The stock price movement in the last 2 hours has been flat. Like all your brain waves. LOL
Give me a break on giving people a heads up. No one on these boards is here to help someone "avoid making a mistake". That is so much BS. No one is here for altruistic reasons. Lets me honest, this is a narcissistic outlet like facebook. We are all here because we like hearing oursleves talk.
Regarding 12%, 10:30 price was around 6.1-6.2, 12:30 price was around 5.85. much less than 12% and really negible. 6.05 are current print.
Nice play glenntrader. I was't going to play this. But when I saw the AH follow through, I too shorted at 8.20. It seemed like a no brainer.
Secondary still a possiblity and makes it worth the play in AH.
Wow are you missing the point. The potential for Proelelex for use on endometriosis is now closer to reality. When people see "endometriosis" on the news wire, they will chase this higher tomorrow morning.
Yep, there is more $$$ potential for endometriosis. People will be chasing RPRX all morning tomorrow!
LOL you jump on a typo...how pathetic. Proellex is also good to help shorts stop their bleeding tomorrow.
touché 8*), though I am not sure I am worthy of looking up past messages. Thanks anyway
I have to admit that I am no longer in TAPM. I bailed after the qtr announcment. I was dissppointed that thier growth had somewhat stagnated from the previous qtr. I know the market in the middle east may help. But I just can't help but wonder if this truley is a commodity based industry now.
I mis judged the potential for TAPM. I will continue to follow it because I have a soft spot for TAPM and I want to see it do well. My biggest concern in the near team would be the need to do a reverse split. That would be disastrous short term.
When you look at the revenue miss of 572M versus 596M estimate, it doesn't look that huge. Except they were expected to easily beat expectations. AND they are trading at a forward PE of 41 with a PEG of 2.72.
This will not be met favorably tomorrow morning. Especially since we will all have to wait until May 3rd for EPS forecast.
12-15 is not a reasonable level for a growth stock. PE range of 25-35 is reasonable.
I shorted last night with the belief that ILMN would test $133 (April 2014 low). But I did not have enough conviction to wait long enough and I covered at 139 (left money on the table, oh well)
I kept one eye on ILMN and when I saw a little capitulation around 133 I decided to go long. Overall investor sentiment is still prett positive on ILMN and I think that many will use this as a buying opportunity. Today's plunge has reeled in the Forward PE to a more reasonable 31.
Somehow I don't think their problems are over. Who is this "forensic investigator"? Very secretive. Sounds suspicious, like an insider. "Big four"?? who?
This may impact earnings a little, but overall a very healthy sign. This has been a pretty volatile stock due to its low float. But with its very low PE and PEG, $81 looks like a great entry point.
I understand why some may have (past tense) thought this was a good stock to short. But Outerwall is diversifying AND there is a larger segment of the population that still needs an option to streaming.
Yes, most of us middle - upper class are willing to pay $120-200/mos for cable and internet. But there are many families that have low cost cable/satelite with no add ons and need a movie option. Redbox won't go away soon and their other businesses are doing just fine.
PE and PEG says buy buy buy. Or cover cover cover.!!